Skip to content

Colonic stenting or surgery in left sided colonic obstruction for disseminated incurable colorectal cancer: a multicenter randomised trial.

Colonic stenting or surgery in left sided colonic obstruction for disseminated incurable colorectal cancer: a multicenter randomised trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON21491
Enrollment
180
Registered
2005-08-22
Start date
2004-12-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

incurable left-sided colonic cancer

Interventions

Sponsors

Prof. Gunning-Schepers, MD, Ph.D. Chaiman Board of Directors PO Box 22660 1100 DD Amsterdam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Left sided colonic cancer (from left flexure to > 10 cm of anus); 2. Diagnosis histological proven; 3. No signs of double tumor; 4. Informed consent.

Exclusion criteria

Exclusion criteria: 1. Potentially curable disease; 2. ASA IV or V; 3. Ileus; 4. Karnofsky index of < 50%.

Design outcomes

Secondary

MeasureTime frame
1. Procedural related hospital stay and mortality and morbidity; 2. Efficacy of palliation of (imminent) obstruction (complaints, secondary operation or stent placement); 3. Quality of life.

Primary

MeasureTime frame
1. Total hospital free survival in good health (corrected for days with a WHO performance status > 1); 2. Integral costs (product of volume consumed care and prices of means (personnel, overhead, material and investments).

Contacts

Public ContactJeanin Hooft, van

Acedemic Medical Center (AMC), Department of Hepato- and Gastroenterology, C2-220, P.O. Box 22660

info@stent-in.nl+31 (0)6 30023579

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)